ArticleThe International journal on drug policy2026
County by county estimation of possible deaths averted, infections averted, and cost savings of overdose prevention centers in the United States from July 2019-June 2025.
Article in The International journal on drug policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
Overdose prevention centers (OPCs), also known as safer injection facilities (SIFs) or supervised consumption sites (SCSs), are a service that allows people to obtain sterile supplies to use their own drugs in a safe environment that is monitored by professionals trained in overdose response and harm reduction. Though still illegal under federal law in the U.S. ("Maintaining Drug-Involved Premises"; "United States v. Safehouse", 2021), many legal or quasi-legal (including some in the U.S.) OPCs have operated since the 1980s. Using CDC overdose death estimates and U.S. Census Bureau population data, we developed a retrospective, scenario-based modeling tool, estimating that 1329-5316 deaths could have been averted between July 2019 and June 2025 if 1 out of 100-400 injections had taken place at an OPC. Under these assumptions, 26-105 HIV transmissions and 5723-22,892 Hepatitis C transmissions could have been averted. Factoring in both discounted lifetime costs to treat those infections as well as the statistical value of deaths averted, $11.9-47.7 billion could have been saved. These data support OPCs as one viable public health intervention to avert deaths and avoid infections. We created a web application that allows users to explore county-level model results and alter model assumptions, including variables like the percent of injections that occur at an OPC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.